missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CBR1 (aa 101-177) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (91%), Rat (91%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53799 (PA5-53799. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Carbonyl reductase is one of several monomeric, NADPH-dependent oxidoreductases having wide specificity for carbonyl compounds. This enzyme is widely distributed in human tissues. Another carbonyl reductase gene, CRB3, lies close to this gene on chromosome 21q.
Specifications
Specifications
| Accession Number | P16152 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 873 |
| Name | Human CBR1 (aa 101-177) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 15-hydroxyprostaglandin dehydrogenase; 15-hydroxyprostaglandin dehydrogenase [NADP(+)]; 20-beta-hydroxysteroid dehydrogenase; AW261796; carbonyl reductase (NADPH) 1; carbonyl reductase [NADPH] 1; Carbonyl reductase [NADPH] 1 (NADPH-dependent carbonyl reductase 1); carbonyl reductase 1; CBR; Cbr 1; Cbr1; CR; CRN; hCBR1; NADPH-dependent carbonyl reductase 1; prostaglandin 9-ketoreductase; Prostaglandin-E(2) 9-reductase; SDR21C1; Short chain dehydrogenase/reductase family 21 C member 1; short chain dehydrogenase/reductase family 21 C, member 1 |
| Common Name | CBR1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction